Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function

Detalhes bibliográficos
Autor(a) principal: Dib, Sergio A. [UNIFESP]
Data de Publicação: 2009
Outros Autores: Gomes, Marilia B.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1186/1758-5996-1-25
http://repositorio.unifesp.br/handle/11600/31124
Resumo: Type 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, in vivo or ex-vivo. the studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. the goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation.
id UFSP_1dbc69871a0b297e2f054bb17cfc90bd
oai_identifier_str oai:repositorio.unifesp.br/:11600/31124
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell functionType 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, in vivo or ex-vivo. the studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. the goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation.Universidade Federal de São Paulo, Dept Med, Div Endocrinol, São Paulo, SP, BrazilUniv Estado Rio de Janeiro, Dept Med, Diabet Div, Rio de Janeiro, GB, BrazilUniversidade Federal de São Paulo, Dept Med, Div Endocrinol, São Paulo, SP, BrazilWeb of ScienceBiomed Central LtdUniversidade Federal de São Paulo (UNIFESP)Universidade do Estado do Rio de Janeiro (UERJ)Dib, Sergio A. [UNIFESP]Gomes, Marilia B.2016-01-24T13:52:00Z2016-01-24T13:52:00Z2009-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion8application/pdfhttp://dx.doi.org/10.1186/1758-5996-1-25Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 1, 8 p., 2009.10.1186/1758-5996-1-25WOS000207918200025.pdf1758-5996http://repositorio.unifesp.br/handle/11600/31124WOS:000207918200025engDiabetology & Metabolic Syndromeinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-07T11:03:34Zoai:repositorio.unifesp.br/:11600/31124Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-07T11:03:34Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
title Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
spellingShingle Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
Dib, Sergio A. [UNIFESP]
title_short Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
title_full Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
title_fullStr Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
title_full_unstemmed Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
title_sort Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
author Dib, Sergio A. [UNIFESP]
author_facet Dib, Sergio A. [UNIFESP]
Gomes, Marilia B.
author_role author
author2 Gomes, Marilia B.
author2_role author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade do Estado do Rio de Janeiro (UERJ)
dc.contributor.author.fl_str_mv Dib, Sergio A. [UNIFESP]
Gomes, Marilia B.
description Type 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, in vivo or ex-vivo. the studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. the goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation.
publishDate 2009
dc.date.none.fl_str_mv 2009-01-01
2016-01-24T13:52:00Z
2016-01-24T13:52:00Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1758-5996-1-25
Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 1, 8 p., 2009.
10.1186/1758-5996-1-25
WOS000207918200025.pdf
1758-5996
http://repositorio.unifesp.br/handle/11600/31124
WOS:000207918200025
url http://dx.doi.org/10.1186/1758-5996-1-25
http://repositorio.unifesp.br/handle/11600/31124
identifier_str_mv Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 1, 8 p., 2009.
10.1186/1758-5996-1-25
WOS000207918200025.pdf
1758-5996
WOS:000207918200025
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Diabetology & Metabolic Syndrome
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 8
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268316504555520